Convergence Financial, LLC Novartis Ag Transaction History
Convergence Financial, LLC
- $501 Billion
- Q4 2024
A detailed history of Convergence Financial, LLC transactions in Novartis Ag stock. As of the latest transaction made, Convergence Financial, LLC holds 3,852 shares of NVS stock, worth $409,313. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,852
Previous 3,794
1.53%
Holding current value
$409,313
Previous $436 Million
14.1%
% of portfolio
0.07%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,439Shares Held
135MCall Options Held
1.12MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA12.2MShares$1.3 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.28 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$860 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$742 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$613 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $229B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...